1. Elferink RO. Cholestasis. Gut 2003;52:ii42-8. [DOI:10.1136/gut.52.suppl_2.ii42]

2. Schmidt O, Pfanner N, Meisinger C. Mitochondrial protein import: from proteomics to functional mechanisms. Nat Rev Mol Cell Biol 2010;11:655-67. [DOI:10.1038/nrm2959]

3. Wang Z, Jiang H, Chen S, Du F, Wang X. The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell 2012;148:228-43. [DOI:10.1016/j.cell.2011.11.030]

4. Hirschfield GM, Heathcote EJ, Gershwin ME. Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology 2010;139:1481-96. [DOI:10.1053/j.gastro.2010.09.004]

5. Trauner M. Molecular alterations of canalicular transport systems in experimental models of cholestasis: possible functional correlations. Yale J Biol Med 1997;70:365-78.

6. Kronsten V, Fitzpatrick E, Baker A. Management of cholestatic pruritus in paediatric patients with alagille syndrome: the King's College Hospital experience. J Pediatr Gastroenterol Nutr 2013;57:149-54. [DOI:10.1097/MPG.0b013e318297e384]

7. Paumgartner G. Medical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets. World J Gastroenterol 2006;12:4445-51. [DOI:10.3748/wjg.v12.i28.4445]

8. Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 2009;30:85-94. [DOI:10.1016/j.tips.2008.11.002]

9. Singh S. From exotic spice to modern drug? Cell 2007;130:765-8. [DOI:10.1016/j.cell.2007.08.024]

10. Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so far. Eur J Cancer 2005;41:1955-68. [DOI:10.1016/j.ejca.2005.05.009]

11. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003;23:363-98.

12. Shishodia S, Sethi G, Aggarwal BB. Curcumin: getting back to the roots. Ann N Y Acad Sci 2005;1056:206-17. [DOI:10.1196/annals.1352.010]

13. Rivera-Espinoza Y, Muriel P. Pharmacological actions of curcumin in liver diseases or damage. Liver Int 2009;29:1457-66. [DOI:10.1111/j.1478-3231.2009.02086.x]

14. Ernst A, Alkass K, Bernard S, Salehpour M, Perl S, Tisdale J, et al. Neurogenesis in the striatum of the adult human brain. Cell 2014;156:1072-83. [DOI:10.1016/j.cell.2014.01.044]

15. Kempermann G, Song H, Gage FH. Neurogenesis in the Adult Hippocampus. Cold Spring Harb Perspect Biol 2015;7:a018812. [DOI:10.1101/cshperspect.a018812]

16. Reza Zarrindast M, Eslimi Esfahani D, Oryan S, Nasehi M, Torabi Nami M. Effects of dopamine receptor agonist and antagonists on cholestasis-induced anxiolytic-like behaviors in rats. Eur J Pharmacol 2013;702:25-31. [DOI:10.1016/j.ejphar.2013.01.023]

17. Wilhelm EA, Jesse CR, Roman SS, Nogueira CW, Savegnago L. Hepatoprotective effect of 3-alkynyl selenophene on acute liver injury induced by D-galactosamine and lipopolysaccharide. Exp Mol Pathol 2009;87:20-6. [DOI:10.1016/j.yexmp.2009.03.004]

18. Chan MM. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol 1995;49:1551-6. [DOI:10.1016/0006-2952(95)00171-U]

19. Kang BY, Chung SW, Chung W, Im S, Hwang SY, Kim TS. Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin. Eur J Pharmacol 1999;384:191-5. [DOI:10.1016/S0014-2999(99)00690-1]

20. Aggarwal BB. Prostate cancer and curcumin: add spice to your life. Cancer Biol Ther 2008;7:1436-40. [DOI:10.4161/cbt.7.9.6659]